Life sciences companies donβt just raise money on data. They raise it on stories.
When youβre developing a therapy that may take 10+ years and millions of dollars to reach patients, the science is central, but without the right financial lens, even the best science can get lost in translation.
Thatβs where a CFO steps in. Our role is more than building models and managing cash flow. We bridge the gap between:
π¬ Scientists who live in the details of the research
π° Investors who want to understand risk, runway, and return
π Boards & partners who need to see how strategy aligns with milestones
In other words, we help turn complex science into clear, credible, and compelling narratives that fund growth and build confidence.
Hereβs what that often looks like in practice:
β’ Translating clinical milestones into financial milestones investors can track
β’ Balancing the βlong-gameβ of R&D with short-term cash realities
β’ Ensuring the story is both visionary and grounded in financial discipline
In my experience, the best fundraises and partnerships happen when science and finance tell the same story.
ππππ πππππππ π
πππππππ π πππππ πππππππππ πππ πππππππ ππ. π³ππβπ πππππ ππ ππππππππ.